VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 94 filers reported holding VISTAGEN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $22,838 | -11.1% | 183,153 | -26.6% | 0.00% | – |
| Q4 2022 | $25,687 | +7.0% | 249,386 | +61.0% | 0.00% | – |
| Q3 2022 | $24,000 | -78.9% | 154,879 | +19.2% | 0.00% | – |
| Q2 2022 | $114,000 | -87.3% | 129,913 | -82.1% | 0.00% | – |
| Q1 2022 | $899,000 | +34.4% | 725,276 | +111.2% | 0.00% | – |
| Q4 2021 | $669,000 | +371.1% | 343,389 | +561.3% | 0.00% | – |
| Q3 2021 | $142,000 | -78.5% | 51,930 | -75.2% | 0.00% | – |
| Q2 2021 | $660,000 | -50.9% | 209,513 | -66.8% | 0.00% | – |
| Q1 2021 | $1,345,000 | +5504.2% | 631,566 | +4934.8% | 0.00% | – |
| Q4 2020 | $24,000 | +166.7% | 12,544 | 0.0% | 0.00% | – |
| Q3 2020 | $9,000 | +28.6% | 12,544 | 0.0% | 0.00% | – |
| Q2 2020 | $7,000 | +16.7% | 12,544 | 0.0% | 0.00% | – |
| Q1 2020 | $6,000 | -33.3% | 12,544 | 0.0% | 0.00% | – |
| Q4 2019 | $9,000 | -30.8% | 12,544 | -0.1% | 0.00% | – |
| Q3 2019 | $13,000 | +44.4% | 12,559 | -0.5% | 0.00% | – |
| Q2 2019 | $9,000 | -43.8% | 12,622 | +0.6% | 0.00% | – |
| Q1 2019 | $16,000 | – | 12,544 | +2712.6% | 0.00% | – |
| Q4 2017 | $0 | – | 446 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Performa Ltd (US), LLC | 4,900 | $9,163 | 0.01% |